Corporate Sponsor |
|
|
|
Sharecare
Sharecare’s solutions for Nephrology practices include virtual patient monitoring for hypertension, diabetes, heart disease, and obesity. Our personalized approach integrates high-touch and high-tech to improve population
health, enhance the patient experience, increase revenue, and minimize disruption to daily workflow. Sharecare offers the strength of many trusted individual solutions with options to bundle each component and create unified actionable
metrics that drive intelligent decision support for the entire healthcare ecosystem. All together better.
|
|
 |
| | | |
Platinum Sponsor |
|
|
| Aurinia is a biopharmaceutical company focused on developing therapies for patient populations impacted by serious diseases with a high unmet medical need. Aurinia received FDA approval for their first commercially available drug product in January 2021. Please visit www.AuriniaLN.com to learn more. | |  |
| | | |
| CareDX is committed to improving transplant patient outcomes by providing innovative and intelligent solutions throughout the entire patient journey. We are a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients. | |  |
| | | |
Chinook Therapeutics is a biotechnology company developing precision medicines for kidney diseases. Chinook’s product candidates, including atrasentan, BION‐1301 and CHK‐336, and research & discovery programs, are being investigated in rare, severe chronic kidney disorders with opportunities for well‐defined clinical pathways. To learn
more, visit www.chinooktx.com.
| |  |
| | | |
Eurofins Transplant Genomics
Transplant Genomics aims to improve transplant outcomes through molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy. | |  |
| | | |
Travere Therapeutics At Travere Therapeutics we are in rare for life. We come together every day to help patients, families and caregivers as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent and we work with the rare disease community to identify, develop and deliver life-changing therapies. We continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. | |  |
| Gold Sponsor | | |
| | | |
Horizon Therapeutics Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.
| |  |
| | | |
Silver Sponsor | | |
ANI Pharmaceuticals
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin® Gel franchise, strengthening our generics business, established brands, and our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com
| |  |
| | | |
| GSK | |  |
| | | |
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. To learn more about Mallinckrodt, visit www.mallinckrodt.com. | |  |
| | |
Bronze Sponsors
|
|
|
Bayer Pharmaceuticals
Bayer is an innovation leader in the area of cardiovascular diseases, with a long-standing commitment to delivering science for a better life by advancing a portfolio of innovative treatments. The heart and the kidneys are closely linked in health and disease, and Bayer is working in a wide range of therapeutic areas on new treatment approaches for cardiovascular and kidney diseases with high unmet medical needs. The cardiology franchise at Bayer already includes a number of products and several other compounds in various stages of preclinical and clinical development. Together, these products reflect the company’s approach to research, which prioritizes targets and pathways with the potential to impact the way that cardiovascular diseases are treated.
| |  |
| | | |
Calliditas Therapeutics
Calliditas is dedicated to expanding treatment options and establishing new standards of care for people with rare diseases. By drawing on our expertise in pharmaceutical product development and leveraging our strategic partnerships, we quickly and efficiently identify, develop, and market a pipeline of innovative medicines that can improve the lives of patients. Recently, we successfully commercialized our lead candidate in the United States, and in collaboration with our partners, launched in Europe, with plans to seek approval in Asia.
| |  |
| | | |
CorMedix CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. | |  |
| | | |
CSL Vifor
CSL Vifor is a global partner of choice for innovative therapies in iron deficiency, dialysis and nephrology & rare disease. We specialize in global partnering, in-licensing and commercializing products with the aim to help patients around the world lead better, healthier lives.
| |  |
| | | |
Healthmap Solutions is an NCQA accredited kidney population health management company serving health plans, health systems, accountable care organizations (ACOs), and provider groups seeking a value-based solution to improve the lives of millions of Americans living with kidney disease. Using its advanced technology, predictive analytics, and clinical expertise Healthmap detects kidney disease early and recommends clinically proven interventions to delay or slow disease progression. Healthmap’s Care Navigation team works with patients and a full spectrum of providers (primary care, nephrologists, cardiologists, endocrinologists, and dialysis providers), to deliver personalized whole-person care. Our approach is to proactively plan care transitions, and optimize renal replacement therapy, with a focus on in-home dialysis treatment and transplant. This approach results in improved care, outcomes, and experience for the person living with kidney disease, while lowering total medical costs for health plans and provider groups.
| |  |
| | | |
| Natera is a global leader in cfDNA testing. Developed by our trusted legacy in cfDNA, the Prospera transplant assessment test is optimized to be a precise and reliable tool for early, clinically-meaningful rejection assessment. Renasight, a renal genetics panel, is a comprehensive, accessible genetic test for patients with CKD. | |  |
| | | |
Developing novel therapies to treat secondary hyperparathyroidism associated with chronic kidney disease
The Renal Division of OPKO Health, Inc. focuses on developing proprietary products to treat secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). We are proud of our lead nephrology product, Rayaldee® (calcifediol), launched in 2016. In addition, the Renal Division is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients. OPKO’s expertise in Vitamin D chemistry, biochemistry, metabolism and physiology, combined with its experience in successfully bringing Vitamin D therapeutics to market uniquely positions the Renal Division to improve the lives of CKD patients.
| |  |
| | | |
Outset Medical The Tablo Dialysis system is the first-of-its-kind, fully integrated system for Adaptive Dialysis. Tablo can treat patients across the care continuum and clinical spectrum, from 24-hour Extended Therapy (XT) in the ICU to home hemodialysis treatments all while reducing the cost and complexity associated with traditional dialysis programs.
| |  |
| | | |
University of Florida Health Pathology Laboratories is the largest academic outreach pathology laboratory in Florida, offering comprehensive pathology services to hospitals
and physician groups throughout the state. To learn more, visit us online at: pathlabs.ufl.edu.
|
|
 |
|
|
| |
| Class 1 Sponsors | | |
| | | |
| Novo Nordisk, a global leader in diabetes care, has been committed to discovering and developing innovative medicines to help people with serious chronic conditions lead longer, healthier lives with fewer limitations. We’re working toward a future where fewer people get diabetes, everyone is diagnosed, and all patients receive adequate treatment. | |  |
| | | |
N'Sync Consulting N'Sync Consulting brings together a unique blend of expertise in the field of End Stage Renal Disease management. Our principals bring over 100 years’ experience in all aspects across the ESRD spectrum. N’Sync Consulting provides comprehensive consulting, management and dialysis billing services to the Renal Disease Industry. | |  |
| | | |
Novartis Pharmaceuticals Novartis is reimagining medicine to improve and extend people’s lives. As leading global medicines company, we focus on five core attractive therapeutic areas and key technology platforms to alleviate some of society’s greatest disease burdens. Ranking among the world’s top companies investing in R&D, our products reach 280 million people globally. | |  |
| RenaCarb™, for the management of metabolic acidosis. Since 1992, Nephro-Tech, Inc. has provided high quality pharmaceuticals. | |  |
| | | |
| | | |
| | | |
| Class 2 Sponsors | | |
| | | |
UF Health Shands Transplant
UF Health transplantation surgeons work closely with a multidisciplinary transplant team to ensure best outcomes. We are a leader in abdominal organ transplantation, performing the first successful kidney transplant in the state in 1966. UF Health physicians have performed transplants for over 4,100 patients with end stage renal disease. This transplant program has celebrated many statewide and regional firsts throughout the years, performing more than 7,000 organ transplants.
| |  |
| | | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Florida Women in Nephrology Chair
FSN President
Print Page